Literature DB >> 27856810

Impacts of chronic kidney disease and diabetes on cardiovascular mortality in a general Japanese population: A 20-year follow-up of the NIPPON DATA90 study.

Aya Hirata1, Tomonori Okamura1, Daisuke Sugiyama1, Kazuyo Kuwabara1, Aya Kadota2,3, Akira Fujiyoshi3, Katsuyuki Miura2,3, Nagako Okuda4, Takayoshi Ohkubo5, Akira Okayama6, Hirotsugu Ueshima2,3.   

Abstract

Background Studies have shown significant associations of chronic kidney disease (CKD) and diabetes mellitus (DM) with cardiovascular disease (CVD) mortality. The impact on the general population is an important public health issue. However, the population attributable fraction (PAF) of CVD because of CKD and/or DM in a general population is uncertain. Methods We followed 7229 participants (age: ≥30 years) with no history of CVD in a Japanese community. We divided participants into four categories according to CKD and/or DM and calculated hazard ratios (HRs) of CVD mortality for each category using a Cox proportional hazards model adjusted for age, dyslipidemia, smoking and alcohol consumption. In addition, PAFs of CVD were estimated among populations with CKD and/or DM. Results During 20-year follow-up, 488 participants died. HRs for CVD were 1.63 [95% confidence interval (CI): 1.16-2.30] with DM only, 1.42 (95% CI: 1.08-1.86) with CKD only and 2.37 (95% CI: 1.40-4.01) with CKD + DM. In men, the corresponding HRs for CVD were 1.88 (95% CI: 1.19-2.97), 1.71 (95% CI: 1.15-2.56) and 3.26 (95% CI: 1.69-6.30), respectively; the corresponding PAFs of CVD were 4.1%, 5.1% and 2.9%, respectively. PAFs for CVD among women were lower than those in men, 1.6% for DM only, 2.0% for CKD only and 0.7% for CKD + DM. Conclusions PAFs of CVD mortality due to CKD and/or DM were not so high in past 20 years; however, they might increase in the future because of recent increase in prevalence of these in Japanese population.

Entities:  

Keywords:  Cardiovascular disease; chronic kidney disease; cohort studies; diabetes; general population; mortality; population attributable fraction

Mesh:

Year:  2016        PMID: 27856810     DOI: 10.1177/2047487316679904

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN: 2047-4873            Impact factor:   7.804


  3 in total

1.  Relationship Between Non-fasting Triglycerides and Cardiovascular Disease Mortality in a 20-year Follow-up Study of a Japanese General Population: NIPPON DATA90.

Authors:  Aya Hirata; Tomonori Okamura; Takumi Hirata; Daisuke Sugiyama; Takayoshi Ohkubo; Nagako Okuda; Yoshikuni Kita; Takehito Hayakawa; Aya Kadota; Keiko Kondo; Katsuyuki Miura; Akira Okayama; Hirotsugu Ueshima
Journal:  J Epidemiol       Date:  2021-06-22       Impact factor: 3.809

2.  Efficacy and safety of trelagliptin in Japanese patients with type 2 diabetes with severe renal impairment or end-stage renal disease: Results from a randomized, phase 3 study.

Authors:  Kohei Kaku; Kazuyuki Ishida; Kohei Shimizu; Meguru Achira; Yuusuke Umeda
Journal:  J Diabetes Investig       Date:  2019-09-19       Impact factor: 4.232

3.  Inflammation as a predictor of acute kidney injury and mediator of higher mortality after acute kidney injury in non-cardiac surgery.

Authors:  Miho Murashima; Masatoshi Nishimoto; Maiko Kokubu; Takayuki Hamano; Masaru Matsui; Masahiro Eriguchi; Ken-Ichi Samejima; Yasuhiro Akai; Kazuhiko Tsuruya
Journal:  Sci Rep       Date:  2019-12-30       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.